On January 4, 2021 BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies targeting specific pathogenic bacteria, reported that Jonathan Solomon, Chief Executive Officer, will participate in the following upcoming investor conferences (Press release, BiomX, JAN 4, 2021, View Source [SID1234573427]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: H.C. Wainwright BioConnect Conference
Dates: January 11-14, 2021
Time: Playback available 6 a.m. EST January 11
Webcast link: BiomX – HCW BioConnect Conference Playback
The webcast will also be available in the Events section of the BiomX website at www.biomx.com.
Event: Oppenheimer Virtual Banking Meeting
Dates: January 11-14, 2021
1×1 meetings only